pharmaphorum

JUNE 11, 2021

He also said that the FDA’s approval was based on the “debatable premise that the drug’s effect on brain amyloid was likely to help patients with Alzheimer’s,” which was not given enough time for discussion at the adcomm meeting.

Drugs 98

Drugs Trials Marketing 98

pharmaphorum

OCTOBER 26, 2022

And just as a family business thrives on its connection to the community, Chiesi is committed to connecting to the global patient community. We try to have a very long-term orientation because we believe that aligns our objectives very well with the objectives of society and the patients we serve, and it makes us a stable business.”.

Development 91

Development Trials Marketing Life Science 91

pharmaphorum

DECEMBER 1, 2020

This structure relies on in-person visits of patients to operate and become profitable. But when the industry suddenly shifted due to COVID-19, so too did the power dynamics of the patient-provider relationship. Burden on the patient. Omri Shor, CEO of Medisafe, explores how. Tech shift.

Pharma Companies 109

Pharma Companies Pharmacy Clinical Trials Clinical Trials 109

pharmaphorum

MARCH 30, 2021

Chris Gray leads Innovation and Ventures for Adelphi’s Healthcare Communications agencies, whose long-running Renaissance series has been discussing the implications of ‘ transformational value ’. As more of these therapies emerge, there are lessons from the front-runners about the need for new approaches starting with clinical trials.

Marketing 66

Marketing Trials Regulation Production 66

Drug Discovery World

NOVEMBER 16, 2022

DDW Editor Reece Armstrong learns about Molecular Devices’ Organoid Innovation Centre (OIC) and how the company is aiming to advance research into 3D biology and organoids. . 3D biology is less common throughout the industry but is starting to make headway due to the benefits it offers scientists.

Drugs 97

Drugs In-Vivo In-Vitro Scientist 97

Drug Discovery World

MARCH 29, 2023

Regulatory data protection (RDP) period RDP refers to the time when generic drug makers cannot refer to an innovator drug’s data to obtain a marketing authorisation 2. According to EFPIA, RDP protects an innovator’s investment by granting a limited period of exclusivity on the data it generated, starting from marketing authorisation 4.

Clinical Trials 52

Clinical Trials Clinical Trials Production Medicine 52

pharmaphorum

SEPTEMBER 13, 2021

After some years of stagnant funding and growth France is now at an inflection point for health care innovation, says Jeito Capital’s Dr Rafaèle Tordjman. To sustain that momentum, France has doubled down on its commitment to fostering innovation here, with the ambition of becoming a leader in Europe by 2030.

Clinical Trials 40

Clinical Trials Clinical Trials Life Science Trials 40

XTalks

MARCH 1, 2021

Lyndon Jones, professor in the School of Optometry & Vision Science at the University of Waterloo, in Ontario, Canada, and Dr. Richard Hom, optometric director at Anthem Blue Cross and Blue Shield, to learn more about mask-associated dry eye and why treatment options are as unique as each patient. What Is Mask-Associated Dry Eye (MADE)?

Sales 119

Sales Drugs Life Science Containment 119

pharmaphorum

MARCH 30, 2021

Alexion’s senior vice president of its international business talks to Paul Tunnah about the importance of “people-centred and vulnerable” leadership, the surprising impacts of COVID and the promising future for treating patients with rare diseases. . Once you start working in rare disease, you get so inspired by the patients.

Genetics 109

Genetics Marketing Development Genome 109

Drug Discovery World

SEPTEMBER 16, 2022

W here globally is innovation occurring and what factors – industry, regulatory, and academia – are helping developers get their products to market? Here, DDW Editor Reece Armstrong explores the global hubs of innovation for cell and gene therapies. The UK stands as one of the key markets for cell and gene therapies.

Gene Therapy 52

Gene Therapy Gene Manufacturing Medicine 52

pharmaphorum

JULY 9, 2021

Digital technologies are proving their value by allowing for better care, improved adherence and a more connected ecosystem between doctors, patients and pharma. In an ideal world, we’d like every patient to have their own pain specialist, psychologist, dietitian, etc.,

Doctors 67

Doctors Doctor Marketing Development 67

pharmaphorum

DECEMBER 7, 2020

His company, UK-based Masters Speciality Pharma , partners with big pharma, SME and biotech companies to bring their products to patients in developing markets. Although Latin America is a vast and varied region, it is one that, generally, presents difficulties for the industry as access to treatments is limited.

Marketing 92

Marketing Regulation Production Medicine 92

pharmaphorum

JANUARY 23, 2023

It was a unique event, at which leaders from across the pharmaceutical pipeline addressed the needs of the industry, shared their own insights, and tackled debates on the crucial topics that influence the future of patient outcomes. It starts with this week, the global population passing eight billion. AI drug discovery? Mountain one.

Life Science 95

Life Science Drugs Medicine Pharma Companies 95

The Pharma Data

MAY 13, 2021

May 13, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced the World Health Organization (WHO) and the government of Sierra Leone have begun administering the Company’s Ebola vaccine regimen as part of a WHO early access clinical program aimed at preventing further spread of Ebola in West Africa. NEW BRUNSWICK, N.J.,

Vaccination 52

Vaccination Vaccine Medicine Clinical Trials 52

Pharmaceutical Technology

JANUARY 26, 2023

Patients with conditions with limited treatment options could one day be cured by these breakthrough therapeutics, with treatments for everything from cancers, Parkinson’s and Alzheimer’s to strokes, spinal cord injuries and diabetes. In turn, this has the potential to enable more people to receive essential treatments.

Gene Therapy 130

Gene Therapy Gene Medicine Manufacturing 130

XTalks

SEPTEMBER 14, 2020

Tension is mounting as nations big and small jockey around industry to ensure they are first in line to access a vaccine, should one prove to be successful against COVID-19. By the end of August, the World Health Organization (WHO) counted 33 vaccine candidates in some stage of clinical trial evaluation.

Vaccination 92

Vaccination Vaccine Antibody Life Science 92